Pediatric Blood & Cancer最新文献

筛选
英文 中文
Abatacept Prevents Severe Acute Graft-Versus-Host Disease Without Increasing Graft Failure Risk in Pediatric Bone Marrow Failure Syndromes. 阿巴接受预防严重的急性移植物抗宿主病而不增加儿童骨髓衰竭综合征的移植物衰竭风险。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-28 DOI: 10.1002/pbc.32085
Zahra Hudda, Stella M Davies, Adam Lane, Deborah E Schiff, Eric J Anderson, Parinda A Mehta, Kasiani C Myers, Nicholas J Gloude
{"title":"Abatacept Prevents Severe Acute Graft-Versus-Host Disease Without Increasing Graft Failure Risk in Pediatric Bone Marrow Failure Syndromes.","authors":"Zahra Hudda, Stella M Davies, Adam Lane, Deborah E Schiff, Eric J Anderson, Parinda A Mehta, Kasiani C Myers, Nicholas J Gloude","doi":"10.1002/pbc.32085","DOIUrl":"https://doi.org/10.1002/pbc.32085","url":null,"abstract":"<p><strong>Background: </strong>Pediatric patients with inherited or acquired bone marrow failure syndromes (BMFS) often require an allogeneic hematopoietic stem cell transplant (HSCT) to cure the hematological manifestations. Amongst these, those without a matched sibling donor (MSD), are at increased risk for graft failure and are known to tolerate graft-versus-host disease (GVHD) poorly. Abatacept (ABA) is Food and Drug Administration (FDA)-approved for the prevention of acute GVHD.</p><p><strong>Objectives: </strong>Our primary objective was to investigate the cumulative incidence (CI) of severe acute (Grade III-IV) GVHD in patients with BMFS undergoing a matched unrelated donor (MUD) or mismatched related or unrelated donor (MMRD/MMUD) HSCT with ABA added to standard GVHD prophylaxis of calcineurin inhibitor and methotrexate or mycophenolate mofetil, and evaluate the incidence of graft failure. Secondary outcomes included overall survival (OS) and acute and chronic GVHD-free graft failure-free overall survival (GFS) at 1 year.</p><p><strong>Study design: </strong>We compared the CI of severe acute GVHD and graft failure by Day 180 in patients who received ABA (n = 26), against a historical cohort of HSCT BMFS patients who did not receive ABA (n = 21) in a combined retrospective review from two centers.</p><p><strong>Results: </strong>None of the patients in the ABA cohort experienced severe (Grade III-IV) acute GVHD compared to 14% in our historical cohort (CI 0% vs. 14%, p = 0.05). All patients in our ABA cohort successfully engrafted, with one patient experiencing poor graft function. In the historical cohort, one patient experienced primary graft failure. The rates of chronic GVHD were comparable between the historical and ABA groups, 28.6% versus 19.2% (p = 0.51). The OS (95.2% vs. 96.0%, p = 0.3) and GFS at 1 year (64.3% vs. 65.3%, p = 0.5) were similar in the ABA group compared to the historical group.</p><p><strong>Conclusion: </strong>ABA was well tolerated in patients with BMFS and prevented severe acute GVHD without increasing the incidence of graft failure. Rates of chronic GVHD and GFS at 1 year were similar, but analysis was limited due to sample size and variability in ABA dosing.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32085"},"PeriodicalIF":2.3,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145186502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral Sinovenous Thrombosis: 20 Years of Experience in a Pediatric Tertiary Center. 脑静脉血栓形成:在儿科三级中心20年的经验。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-26 DOI: 10.1002/pbc.32083
Julia Loureiro Sion, Daniele M Celeste, Bernadete L Liphaus, Marlene P Garanito, Jorge D A Carneiro
{"title":"Cerebral Sinovenous Thrombosis: 20 Years of Experience in a Pediatric Tertiary Center.","authors":"Julia Loureiro Sion, Daniele M Celeste, Bernadete L Liphaus, Marlene P Garanito, Jorge D A Carneiro","doi":"10.1002/pbc.32083","DOIUrl":"https://doi.org/10.1002/pbc.32083","url":null,"abstract":"<p><p>Cerebral sinovenous thrombosis (CSVT) is rare in children and is related to risk factors, as dehydration and infections. This study analyzed 44 pediatric cases of CSVT from a 20-year registry. Risk factors were identified in 93%, infection being the most frequent. Thrombophilia was detected in eight patients. Most patients (91%) received anticoagulation: 78% low molecular weight heparin and 20% unfractionated heparin. Treatment duration exceeded current recommendations (median 21 weeks), as most cases were treated based on CHEST 2012 guidelines. One patient experienced major bleeding related to anticoagulation. All thrombi improved, with 49% achieving complete resolution. There were no recurrences and no fatalities linked to anticoagulation.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32083"},"PeriodicalIF":2.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145177227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytarabine-Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia. 阿糖胞苷相关神经毒性与婴儿急性淋巴细胞白血病。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-26 DOI: 10.1002/pbc.32087
Ashley C Holland, Margit K Mikkelsen, Soniya Pinto, Noah D Sabin, Lu Wang, Bradley Muller, Raja B Khan, Hiroto Inaba
{"title":"Cytarabine-Related Neurotoxicity in an Infant With Acute Lymphoblastic Leukemia.","authors":"Ashley C Holland, Margit K Mikkelsen, Soniya Pinto, Noah D Sabin, Lu Wang, Bradley Muller, Raja B Khan, Hiroto Inaba","doi":"10.1002/pbc.32087","DOIUrl":"https://doi.org/10.1002/pbc.32087","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32087"},"PeriodicalIF":2.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145177234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Pigmented Mesoblastic Nephroma With Melanocytic Features. 有黑素细胞特征的色素中胚层肾瘤1例。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-26 DOI: 10.1002/pbc.32078
Amine Bouachba, Gessica Lobascio, Philippe Drabent, Pascale Philippe Chomette, Gaelle Pierron, Dominique Berrebi
{"title":"A Case of Pigmented Mesoblastic Nephroma With Melanocytic Features.","authors":"Amine Bouachba, Gessica Lobascio, Philippe Drabent, Pascale Philippe Chomette, Gaelle Pierron, Dominique Berrebi","doi":"10.1002/pbc.32078","DOIUrl":"https://doi.org/10.1002/pbc.32078","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32078"},"PeriodicalIF":2.3,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145177216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient. 成功使用马里巴韦在儿童HSCT患者的二次巨细胞病毒预防。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-25 DOI: 10.1002/pbc.32090
Broadman Joshua, Erin Barthelmess Goodell, Donna J Curtis, Laura McLaughlin, Amanda Strommen, Katherine T Lind
{"title":"Successful Use of Maribavir for Secondary CMV Prophylaxis in a Pediatric HSCT Patient.","authors":"Broadman Joshua, Erin Barthelmess Goodell, Donna J Curtis, Laura McLaughlin, Amanda Strommen, Katherine T Lind","doi":"10.1002/pbc.32090","DOIUrl":"https://doi.org/10.1002/pbc.32090","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32090"},"PeriodicalIF":2.3,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improving Implementation of the Psychosocial Standards of Care Together. 共同改善社会心理护理标准的实施。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-25 DOI: 10.1002/pbc.32088
Leandra Desjardins
{"title":"Improving Implementation of the Psychosocial Standards of Care Together.","authors":"Leandra Desjardins","doi":"10.1002/pbc.32088","DOIUrl":"https://doi.org/10.1002/pbc.32088","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32088"},"PeriodicalIF":2.3,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LINE-1 Retroelement Activation and Neuroinflammation in Persons With Fanconi Anemia. 范可尼贫血患者的LINE-1逆转录因子激活和神经炎症。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-25 DOI: 10.1002/pbc.32081
Allison L Bartlett, Kristie N Ramos, Jamen R Bartlett, Kenneth S Ramos, Nathan Luebbering, Kasiani C Myers, Parinda A Mehta, Stella M Davies
{"title":"LINE-1 Retroelement Activation and Neuroinflammation in Persons With Fanconi Anemia.","authors":"Allison L Bartlett, Kristie N Ramos, Jamen R Bartlett, Kenneth S Ramos, Nathan Luebbering, Kasiani C Myers, Parinda A Mehta, Stella M Davies","doi":"10.1002/pbc.32081","DOIUrl":"https://doi.org/10.1002/pbc.32081","url":null,"abstract":"<p><p>We describe the first immunohistochemical analysis performed on brain lesion biopsies from two young individuals with Fanconi anemia neuroinflammatory syndrome (FANS). We identified aberrant activation of the LINE-1 retrotransposon as a novel mechanism of neuroinflammation in individuals with hematological disorders. LINE-1 ORF-1 protein is upregulated in biopsies of inflammatory lesions compared to brain tissue from persons with FA without FANS, and shows activation of an innate immune response with increased STING and IFI6 expression. Awareness among hematologists is vital, as this condition can mimic an aggressive brain tumor both clinically and radiographically, and the proposed mechanism has meaningful therapeutic implications.</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32081"},"PeriodicalIF":2.3,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145150239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Safety and Efficacy of Ruxolitinib in an Infant With Familial Hemophagocytic Syndrome Type 3: A Bridging Therapy Toward Hematopoietic Cell Transplantation and Treatment of Post-Transplant Complications, Including Sinusoidal Obstruction Syndrome. 鲁索利替尼治疗家族性吞噬细胞综合征3型婴儿的安全性和有效性:造血细胞移植的桥接疗法和移植后并发症的治疗,包括鼻窦阻塞综合征。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-24 DOI: 10.1002/pbc.32073
Kazuki Takahashi, Shinsuke Hirabayashi, Masahiro Ueki, Masataka Hasegawa, Hiroki Ohata, Shunichiro Takezaki, Yukayo Terashita, Yuko Cho, Atsushi Manabe
{"title":"The Safety and Efficacy of Ruxolitinib in an Infant With Familial Hemophagocytic Syndrome Type 3: A Bridging Therapy Toward Hematopoietic Cell Transplantation and Treatment of Post-Transplant Complications, Including Sinusoidal Obstruction Syndrome.","authors":"Kazuki Takahashi, Shinsuke Hirabayashi, Masahiro Ueki, Masataka Hasegawa, Hiroki Ohata, Shunichiro Takezaki, Yukayo Terashita, Yuko Cho, Atsushi Manabe","doi":"10.1002/pbc.32073","DOIUrl":"https://doi.org/10.1002/pbc.32073","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32073"},"PeriodicalIF":2.3,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145138143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France. 法国早产儿接受神经母细胞瘤化疗的结果
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-24 DOI: 10.1002/pbc.32027
Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher, Julien Lejeune
{"title":"Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France.","authors":"Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher, Julien Lejeune","doi":"10.1002/pbc.32027","DOIUrl":"https://doi.org/10.1002/pbc.32027","url":null,"abstract":"<p><p>Neuroblastoma is the most common extracranial solid tumor in children, and congenital forms account for 5% of all neuroblastoma cases. In utero diagnosis is very rare, and the progression leading to premature delivery for urgent treatment is exceptional. In some of these cases, chemotherapy is required after birth, given tumor progression that threatens the functional prognosis (dumbbell neuroblastoma), or even survival (Stage MS). However, the optimal doses of chemotherapy in premature newborns are not known. We present a retrospective cohort of six patients treated in French pediatric oncology centers in order to analyze treatment modalities, and report on their tolerance (five Grade 4 hematological toxicity, three septicemias) as well as the outcome of these newborns (two deaths, four remissions).</p>","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32027"},"PeriodicalIF":2.3,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145138169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Myeloid Leukemia With KAT6A Deletion in a 7-Week-Old. 7周大急性髓系白血病伴KAT6A缺失。
IF 2.3 3区 医学
Pediatric Blood & Cancer Pub Date : 2025-09-23 DOI: 10.1002/pbc.32077
Ingrid S Tam, Savio S T Nguyen, Andrea Hawrysh, Christopher S Pharis, Paul R D'Alessandro
{"title":"Acute Myeloid Leukemia With KAT6A Deletion in a 7-Week-Old.","authors":"Ingrid S Tam, Savio S T Nguyen, Andrea Hawrysh, Christopher S Pharis, Paul R D'Alessandro","doi":"10.1002/pbc.32077","DOIUrl":"https://doi.org/10.1002/pbc.32077","url":null,"abstract":"","PeriodicalId":19822,"journal":{"name":"Pediatric Blood & Cancer","volume":" ","pages":"e32077"},"PeriodicalIF":2.3,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145125650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信